| |

Cancer Nurs
2002 Feb;25(1):50-6
Calcium Research:
Postmenopausal survivors of breast cancer at risk for osteoporosis:
nutritional intake and body size.
Lindsey AM,
Gross G, Twiss J, Waltman N, Ott C, Moore TE.
College of
Nursing, University of Nebraska Medical Center, Omaha 68198-5330, USA.
alindsey@unmc.edu
Postmenopausal
survivors of breast cancer for whom hormone replacement therapy is
contraindicated are at risk for development of osteoporosis. The primary
purpose of this article is to describe, in a sample of 30 postmenopausal
survivors of breast cancer, their calcium and vitamin D intake compared
with recommended dietary guidelines for those nutrients for
postmenopausal women not taking hormone replacement therapy and the body
mass index of these women as nutritional status risk factors for
development of osteoporosis. Bone health and presence of osteoporosis
were determined by bone mineral density testing of the spine, hip, and
forearm. To obtain calcium and vitamin D intake, including supplements,
3-day diet records were completed; height and weight measures were used
to calculate body mass index. The sample participants ranged in age from
42 to 65 years; the majority (56%) had been menopausal or off hormone
replacement therapy for 5 years or less, and 70% had completed breast
cancer treatment for 5 years or less (except tamoxifen). The majority
(63%) were of medium body frame size; 30% were of small frame size. The
mean body mass index (27.3) and mean weight (160 lbs) indicate that
these women, as a group, were over-weight. Although a large percent
(63%) were taking calcium supplements, the mean daily intake (diet and
supplements) of calcium (1,353 mg) and vitamin D (403 IU) was less than
the recommended dietary guidelines for these nutrients in this
population. At study entry, 80% of the women were osteopenic (60%) or
osteoporotic (20%) and none was receiving treatment/prevention for
osteoporosis; only 1 had a previous known osteoporosis diagnosis. This
is a special group of women for whom screening and preventive strategies
for osteoporosis are imperative.
|
|